BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
UBS
Cantor Fitzgerald
Farmers Insurance
Argus Health
Queensland Health
Johnson and Johnson
Dow
Medtronic

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074481

« Back to Dashboard

NDA 074481 describes CAPTOPRIL, which is a drug marketed by Apotex, Apothecon, Boscogen, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Mylan Pharms Inc, Par Pharm, Prinston Inc, Purepac Pharm, Sandoz, Teva, Vintage Pharms Llc, Watson Labs, Wockhardt, Ivax Sub Teva Pharms, and Mylan, and is included in twenty-eight NDAs. It is available from twenty-eight suppliers. Additional details are available on the CAPTOPRIL profile page.

The generic ingredient in CAPTOPRIL is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
Summary for 074481
Tradename:CAPTOPRIL
Applicant:Sandoz
Ingredient:captopril
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 074481

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength12.5MG
Approval Date:Feb 13, 1996TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG
Approval Date:Feb 13, 1996TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Feb 13, 1996TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Merck
Queensland Health
Johnson and Johnson
Daiichi Sankyo
Boehringer Ingelheim
Covington
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot